Identification and characterization of riproximin, a new type II ribosome-inactivating protein with antineoplastic activity from Ximenia americana

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Cristina VossMartin R Berger

Abstract

The aim of this study was to identify and characterize the active component(s) of Ximenia americana plant material used to treat cancer in African traditional medicine. By a combination of preextraction, extraction, ion exchange and affinity chromatography, a mixture of two cytotoxic proteins was isolated. Using degenerated primers designed on the de novo sequence of two tryptic peptides from one of these proteins, a DNA fragment was amplified and the sequence obtained was used to determine the complete cDNA sequence by the RACE method. Sequence analysis and molecular modeling showed that the new protein, riproximin, belongs to the family of type II ribosome inactivating proteins. These results are in good agreement with the ability of riproximin to inhibit protein synthesis in a cell-free system, as well as with the cytotoxicity of riproximin, as demonstrated by its IC50 value of 0.5 pM in MCF7, 1.1 pM in HELA and 0.6 pM in CC531-lacZ cells. To assess the antineoplastic efficacy of the purified riproximin in vivo, the CC531-lacZ colorectal cancer rat metastasis model was used. Significant anticancer activity was found after administration of total dosages of 100 (perorally) and 10 (intraperitoneally) pmol riproximin/kg. These ...Continue Reading

References

Jan 1, 1991·Proteins·E RutenberJ D Robertus
Apr 9, 1987·Nature·E RutenberJ D Robertus
Jul 18, 1970·Nature·J Y LinT C Tung
Dec 21, 1993·Biochimica Et Biophysica Acta·L BarbieriF Stirpe
Nov 1, 1995·Protein Science : a Publication of the Protein Society·C N PaceT Gray
May 23, 1996·Nature·R W HooftE E Abola
Nov 22, 1996·Journal of Molecular Biology·J PontiusS J Wodak
Dec 1, 1996·Analytical Biochemistry·M LangerH Zinke
Aug 4, 1998·International Journal of Cancer. Journal International Du Cancer·S M KonstantinovM R Berger
Apr 13, 1999·Biochemical and Biophysical Research Communications·R KrauspenhaarC Betzel
Sep 22, 1999·European Journal of Biochemistry·J EckH Lentzen
Jun 26, 2003·Nucleic Acids Research·Torsten SchwedeManuel C Peitsch
Sep 19, 2003·Molecular Biotechnology·Jürgen Krauss
Oct 29, 2003·Toxicological Reviews·Michael J LordLynne M Roberts
Dec 4, 2003·Biochemical Society Transactions·J M LordL M Roberts
Dec 23, 2003·European Journal of Biochemistry·Catherine J MarsdenJ Michael Lord
Jan 24, 2004·Journal of Cancer Research and Clinical Oncology·Jan SaengerMartin R Berger
Mar 26, 2004·Cancer Detection and Prevention·Ian F PrymeUwe Pfüller
Apr 6, 2004·FEBS Letters·Luigi BarbieriFiorenzo Stirpe
Jun 8, 2004·Mini Reviews in Medicinal Chemistry·Martin R Hartley, J Michael Lord
Jun 8, 2004·Mini Reviews in Medicinal Chemistry·Maria Giulia Battelli
Aug 4, 2004·Cellular and Molecular Life Sciences : CMLS·M G BattelliF Stirpe
Aug 11, 2004·Toxicon : Official Journal of the International Society on Toxinology·Fiorenzo Stirpe
Nov 20, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P SchöffskiUNKNOWN European Organization for Research and Treatment of Cancer New Drug Development Group
May 26, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P SchöffskiH Lentzen

❮ Previous
Next ❯

Citations

Apr 7, 2010·Cellular and Molecular Life Sciences : CMLS·Martin Frank, Siegfried Schloissnig
Aug 9, 2012·The Journal of Biological Chemistry·Helene BayerCristina Voss
Dec 30, 2008·Journal of Ethnobiology and Ethnomedicine·Tom Erik GrønhaugBerit Smestad Paulsen
Sep 17, 2010·Cellular and Molecular Life Sciences : CMLS·C HorrixM R Berger
May 27, 2015·Toxins·Joachim SchrotMatthias F Melzig
Apr 10, 2012·Drug Discovery Today·Munish PuriRaghbir C Gupta
Jul 15, 2015·Journal of Cancer Research and Clinical Oncology·Asim PervaizMartin R Berger
Sep 10, 2014·ACS Chemical Biology·Arren Z WashingtonAdegboyega K Oyelere
Sep 29, 2009·Toxicon : Official Journal of the International Society on Toxinology·Jonathan LeshinKenneth Dretchen
Dec 3, 2009·Proteomics·Joerg SeidlerWolf D Lehmann
Jul 18, 2015·Chinese Journal of Cancer·Meiqi ZengOu Sha
Dec 20, 2011·Protein Expression and Purification·Helene BayerMartin R Berger
Jan 30, 2008·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Ping-Lin OngChing-Hsein Chen
Jun 12, 2014·Cancer Biology & Therapy·Hassan AdwanMartin R Berger

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Toxicon : Official Journal of the International Society on Toxinology
Sjur Olsnes
Toxicon : Official Journal of the International Society on Toxinology
F Stirpe
Cellular and Molecular Life Sciences : CMLS
F Stirpe, M G Battelli
© 2022 Meta ULC. All rights reserved